Data from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
Identification
- Public canonical key
- radar:r-24ad64deee087d4444b09d4f891c757e
- Authors
- Andreas Zingg · Reto Ritschard · Helen Thut · Mélanie Buchi · Andreas Holbro · Anton Oseledchyk · Viola A Heinzelmann-Schwarz · Andreas S. Buser · Mascha Binder · Alfred Zippelius · Natália Rodrigues Mantuano · Matthias Sebastian Matter · Heinz Philipp Laubli
- Reported year
- 2025
- Reported language
- en
- Source type
- other
- First detected
- 2026-11-14T02:03:13.964166+00:00
- Last metadata observation
- 2026-11-14T02:03:13.964166+00:00
- Last HTTP verification
- Not checked
Documentary abstract — original language
Abstract Chimeric antigen receptor (CAR) T-cell therapy has improved outcomes for patients with chemotherapy-resistant B-cell malignancies. However, CAR T-cell treatment of patients with solid cancers has been more difficult, in part because of the heterogeneous expression of tumor-specific cell surface antigens. In this study, we describe the generation of a fully human CAR targeting altered glycosylation in secretory epithelial cancers. The expression of the target antigen—the truncated, sialylated O-glycan Sialyl-Thomsen-nouveau (STn) antigen—was studied with a highly STn-specific antibody across various different tumor tissues. Strong expression was found in a high proportion of gastrointestinal cancers, including pancreatic cancers, and in gynecologic cancers, in particular ovarian and endometrial tumors. T cells expressing anti-STn CAR were tested in vitro and in vivo. Anti-STn CAR T cells showed activity in mouse models, as well as in assays with primary ovarian cancer samples. No considerable toxicity was observed in mouse models although some intraluminal expression of STn was found in gastrointestinal mouse tissue. Taken together, this fully human anti-STn CAR construct shows promising activity in preclinical tumor models, supporting its further evaluation in early clinical trials.
Identifiers
- OPENALEX
- https://openalex.org/W4411967052
- DOI
- 10.1158/2326-6066.c.7906456
Documentary context
- Documentary family
- unknown
- Source-reported types
- other
Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.
Sources
OpenAlex · Record 1
Cite this reference
Andreas Zingg; Reto Ritschard; Helen Thut; Mélanie Buchi; Andreas Holbro; Anton Oseledchyk; Viola A Heinzelmann-Schwarz; Andreas S. Buser; Mascha Binder; Alfred Zippelius; Natália Rodrigues Mantuano; Matthias Sebastian Matter; Heinz Philipp Laubli. Data from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors. 2025. https://doi.org/10.1158/2326-6066.c.7906456
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.
- APA
- Andreas Zingg; Reto Ritschard; Helen Thut; Mélanie Buchi; Andreas Holbro; Anton Oseledchyk; Viola A Heinzelmann-Schwarz; Andreas S. Buser; Mascha Binder; Alfred Zippelius; Natália Rodrigues Mantuano; Matthias Sebastian Matter; Heinz Philipp Laubli. (2025). Data from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors. https://doi.org/10.1158/2326-6066.c.7906456
- Chicago
- Andreas Zingg; Reto Ritschard; Helen Thut; Mélanie Buchi; Andreas Holbro; Anton Oseledchyk; Viola A Heinzelmann-Schwarz; Andreas S. Buser; Mascha Binder; Alfred Zippelius; Natália Rodrigues Mantuano; Matthias Sebastian Matter; Heinz Philipp Laubli. Data from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors. 2025. https://doi.org/10.1158/2326-6066.c.7906456
- ISO 690
- Andreas Zingg; Reto Ritschard; Helen Thut; Mélanie Buchi; Andreas Holbro; Anton Oseledchyk; Viola A Heinzelmann-Schwarz; Andreas S. Buser; Mascha Binder; Alfred Zippelius; Natália Rodrigues Mantuano; Matthias Sebastian Matter; Heinz Philipp Laubli. Data from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors. 2025. https://doi.org/10.1158/2326-6066.c.7906456
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR Global Rights of Nature Legal Library. Data from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-24ad64deee087d4444b09d4f891c757e/ · Last HTTP verification: not performed
Research dossiers and documentary relations
Source roles
Bibliographic / original publication source · https://doi.org/10.1158/2326-6066.c.7906456
An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.
Documentary status
Relevance pending
Library
This identity is not yet included in the Legal Library.